Skip to main content
Article
Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial.
Articles, Abstracts, and Reports
  • J A Walsh
  • A B Gottlieb
  • B Hoepken
  • T Nurminen
  • P J Mease, Swedish Medical Center and University of Washington, Seattle, WA, USA.
Document Type
Article
Publication Date
12-1-2018
Disciplines
Abstract

The above article originally published with an error present in Discussion section and presented correctly in this article. The original article was corrected.

Area of Special Interest
Orthopedics & Sports Medicine
Specialty/Research Institute
Orthopedics
Specialty/Research Institute
Rheumatology
Citation Information
J A Walsh, A B Gottlieb, B Hoepken, T Nurminen, et al.. "Correction to: Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial." (2018)
Available at: http://works.bepress.com/philip-mease/375/